Protective effects of baicalein and wogonin against benzo[a]pyrene- and aflatoxin B1-induced genotoxicities

Biochemical Pharmacology

Volumn 62, Issue 12, 2001, Pages 1653-1660

  Ueng, Yune Fang ^a   Shyu, Chi Chuo ^b   Liu, Tsung Yun ^b,c   Oda, Yoshimitsu ^d   Lin, Yun Lian ^a   Liao, Jyh Fei ^b   Chen, Chieh Fu ^a,b  

^a NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Aflatoxin B1; Baicalein; Benzo a pyrene; Cytochrome P450; Liver; Wogonin

Indexed keywords

AFLATOXIN; AFLATOXIN B1; AFLATOXIN Q1; ANTINEOPLASTIC AGENT; BAICALEIN; BENZO[A]PYRENE; FLAVONOID; UNCLASSIFIED DRUG; WOGONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIET; DNA ADDUCT; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; EPOXIDATION; GENE EXPRESSION; GENOTOXICITY; HYDROXYLATION; IC 50; LIVER MICROSOME METABOLISM; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

AFLATOXIN B1; ANIMALS; BENZO(A)PYRENE; DIET; DRUG INTERACTIONS; FLAVANONES; FLAVONOIDS; HYDROXYLATION; MALE; MICE; MICE, INBRED C57BL; MICROSOMES, LIVER; MUTAGENICITY TESTS; NADPH-FERRIHEMOPROTEIN REDUCTASE; PROTECTIVE AGENTS;

EID: 0035894191     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00816-4     Document Type: Article

References (44)

1. Risk assessment for benzo(a)pyrene
2. Mechanisms of aflatoxin carcinogenesis
3. A follow-up study of urinary markers of aflatoxin exposure, and liver cancer risk in Shanghai, People's Republic of China
4. Oxidation of benzo(a)pyrene by recombinant human cytochrome P450 enzymes
5. 1 by bacterial recombinant human cytochrome P450 enzymes
6. Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite
7. 1-DNA adducts: Linear correlation with hepatic cancer risk
8. Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites
9. Chemoprevention of cancer
10. Flavonoids: Old, and new aspects of a class of natural therapeutic drugs
11. 1 activation in human liver microsomes by naringenin, and other flavonoids
12. 1 metabolism in human liver microsomes by naturally occurring flavonoids
13. In vitro, and in vivo effects of naringin on cytochrome P450-dependent monooxygenase in mouse liver
14. Effects of baicalein and wogonin on drug-metabolizing enzymes in C57BL/6J mice
15. Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis
16. In vivo hepatoprotective effect of baicalein, and wogonin from Scutellariae rivularis
17. Studies on Scutellariae radix. XII. Anti-thrombic actions of various flavonoids from Scutellariae radix
18. Inhibitory effect of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in benzo[a]pyrene-initiated CD-1 mouse skin by baicalein
19. Antimutagenic effects of flavonoids, chalcones and structurally related compounds on the activity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and other heterocyclic amine mutagens from cooked food
20. Effects of nine active ingredients in Chinese herbal medicine Sho-saiko-to on 2-(2-furyl)-3-(5-nitro-2-furyl) acrylamide mutagenicity
21. Mutagenicity of flavones, chromones and acetophenones in Salmonella typhimurium. New structure-activity relationships
22. Determination of wogonin in rat plasma by liquid chromatography and its pharmacokinetic application
23. Gene and chromosome analysis
24. Validation of the SOS/umu test using results of 486 chemicals and comparison with Ames test and carcinogenicity data
25. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemeprotein nature
26. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: Isolation, characterization, and kinetic studies
27. Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assembly and properties of induced enzyme
28. 1 exo- and endo-epoxide by rat and human glutathione S-transferases
29. Protein measurement with the Folin phenol reagent
30. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo
31. Differential sensitivity of human hepatoma cell line and primary rat hepatocyte culture to benzo(a)pyrene-induced unscheduled DNA synthesis and adduct formation
32. Dietary flavonoids: Intake, health effects, and bioavailability
33. Effects of medicinal plant extracts from Chinese herbal medicines on the mutagenic activity of benzo[a]pyrene
34. Modulation of cytochrome P-450IA1-mediated mutagenicity, DNA binding and metabolism of benzo[a]pyrene by Chinese medicinal herbs
35. Baicalein, an in vitro antigenotoxic compound from Scutellaria baicalensis
36. Current status of treatment of hepatobiliary disorders in Japan. Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma
37. Characteristics of delayed excretion of flavonoids in human urine after administration of Shosaiko-to, a herbal medicine
38. Mechanism of antioxidant action of pueraria glycoside (PG-1) (an isoflavonoid) and mangiferin (a xanthonoid)
39. A microsomal membrane component associated with iron reduction in NADPH-supported lipid peroxidation
40. Biliary excretion of metabolites of baicalin and baicalein in rats
41. 1
42. Herbal hepatotoxicity: Revisiting a dangerous alternative
43. Examination of coumarins, flavonoids and polysaccharopeptide for antibacterial activity
44. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines